sprout health tirzepatide Home Tirzepatide Patient Education Handouts: Weight
Description
Retrieved April 27, 2023 from [4] Tirzepatide Once Weekly for the Treatment of Obesity [5] Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial,
Thyroid C-Cell Tumors: In mice and rats, tirzepatide (the active ingredient in Zepbound and Mounjaro) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Highly recommended
The calculator handles other vial sizes and BAC volumes
A vial labeled 10mg/mL contains 10 milligrams of active tirzepatide per milliliter of liquid
